| 摘要 |
The present invention relates to a method to determine predisposition to coagulation disorders, such as thrombosis, to a method for diagnosis of lupus, and therapeutical uses thereof in the treatment of coagulation disorders. More specifically, the present invention relates to a method to determine predisposition to coagulation disorders in a patient, which comprises the step of determining the presence or absence of anti-lamin B1 (aLB1) antibodies and of lupus anticoagulant (LA) antibodies; and wherein presence of aLB1 and LA antibodies is indicative of a low risk of coagulation disorders incidence
|
